Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?
- PMID: 17579588
- DOI: 10.1038/ncpgasthep0869
Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?
Comment on
-
Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis.Am J Transplant. 2007 Jan;7(1):185-94. doi: 10.1111/j.1600-6143.2006.01591.x. Am J Transplant. 2007. PMID: 17227567